These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 16434595)
1. Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines. Fisher JA; Fikry C; Troxel AB Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):108-13. PubMed ID: 16434595 [TBL] [Abstract][Full Text] [Related]
2. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies. Sharaf RN; Ladabaum U Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of screening for colorectal cancer in the general population. Frazier AL; Colditz GA; Fuchs CS; Kuntz KM JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892 [TBL] [Abstract][Full Text] [Related]
4. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence. Inadomi JM J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia. Tsoi KK; Ng SS; Leung MC; Sung JJ Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Sonnenberg A; Delcò F; Inadomi JM Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584 [TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness and projected national impact of colorectal cancer screening in France. Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557 [TBL] [Abstract][Full Text] [Related]
8. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. Lansdorp-Vogelaar I; van Ballegooijen M; Zauber AG; Habbema JD; Kuipers EJ J Natl Cancer Inst; 2009 Oct; 101(20):1412-22. PubMed ID: 19779203 [TBL] [Abstract][Full Text] [Related]
9. Screening for colorectal cancer: the cost to find an advanced adenoma. McGrath JS; Ponich TP; Gregor JC Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests. Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. Knudsen AB; Lansdorp-Vogelaar I; Rutter CM; Savarino JE; van Ballegooijen M; Kuntz KM; Zauber AG J Natl Cancer Inst; 2010 Aug; 102(16):1238-52. PubMed ID: 20664028 [TBL] [Abstract][Full Text] [Related]
12. Fecal occult blood testing when colonoscopy capacity is limited. Wilschut JA; Habbema JD; van Leerdam ME; Hol L; Lansdorp-Vogelaar I; Kuipers EJ; van Ballegooijen M J Natl Cancer Inst; 2011 Dec; 103(23):1741-51. PubMed ID: 22076285 [TBL] [Abstract][Full Text] [Related]
13. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer. Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330 [TBL] [Abstract][Full Text] [Related]
14. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M; J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: performances of immunochemical colorectal cancer screening. Berchi C; Guittet L; Bouvier V; Launoy G Int J Technol Assess Health Care; 2010 Jan; 26(1):48-53. PubMed ID: 20059780 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries. Wu GH; Wang YM; Yen AM; Wong JM; Lai HC; Warwick J; Chen TH BMC Cancer; 2006 May; 6():136. PubMed ID: 16723013 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy. O'Leary BA; Olynyk JK; Neville AM; Platell CF J Gastroenterol Hepatol; 2004 Jan; 19(1):38-47. PubMed ID: 14675241 [TBL] [Abstract][Full Text] [Related]
18. Modeling the cost-effectiveness of colorectal cancer screening: policy guidance based on patient preferences and compliance. Subramanian S; Bobashev G; Morris RJ Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1971-8. PubMed ID: 19567507 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of colorectal cancer screening methods in Iran. Allameh Z; Davari M; Emami MH Arch Iran Med; 2011 Mar; 14(2):110-4. PubMed ID: 21361717 [TBL] [Abstract][Full Text] [Related]
20. [Arguments against implementing a population-based screening programme for colorectal cancer]. Bonneux L Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]